Evaluation of the efficacy and safety of Capsule LongvidaÂ® Optimized Curcumin in knee osteoarthritis: A randomized double-blind controlled clinical study

Pharmanza Herbal PvtLtd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•Patients of either sex, 40 to 60 years of age diagnosed with osteoarthritis of the knee based on the American College of Rheumatology (ACR)criteria and patient willing to comply with study procedures and requirements.

•1.Patients with congenital arthropathy, rheumatoid arthritis, active gout, other type of arthritis with/without inflammation e.g. septic , fibromyalgia or collagen vascular disease
•2.Patients with known history of coagulopathies
•3.Osteoarthritis of any other joint except knee
•4.Patients with history of major trauma or surgery in the knee joint
•5.Patients with uncontrolled diabetes and hypertension
•6.Body mass index (BMI) >40 kg/m2.
•7.Patients with any severe cardiac, renal and hepatic disease
•8.Pregnant and lactating women
•9.Patients who participated in any clinical trial within 30 days before enrollment into the study

发起方

Pharmanza Herbal PvtLtd